Ignite Creation Date:
2025-12-24 @ 7:46 PM
Ignite Modification Date:
2026-01-28 @ 3:29 PM
Study NCT ID:
NCT00538603
Status:
COMPLETED
Last Update Posted:
2015-12-17
First Post:
2007-10-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)
Sponsor:
King Faisal Specialist Hospital & Research Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RAC #2051-062
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None